WASP and WAVE proteins: vital intrinsic regulators of cell motility and their role in cancer (Review) by Fernando, Herman S. et al.
Abstract. Cell migration is critical during the metastatic spread
of cancer cells. Metastases, rather than primary tumours, are
responsible for most cancer-related deaths. Invasive cancer
cells acquire a migratory phenotype which is associated with
an increased expression of several genes involved in cell
motility. Actin, which is the most abundant protein in most
eukaryotic cells, is necessary for whole cell locomotion.
Reorganisation of actin filaments is regulated by a highly
integrated signalling cascade governed by ‘molecular switches’
which belong to the Rho GTPase family. WASP family
proteins are downstream molecules which form a link between
the GTPases and the actin cytoskeleton. The WASP family
includes 5 members and is structurally divided into 2 groups:
Wiskott-Aldrich Syndrome proteins (WASPs) and WASP
verprolin homologous proteins (WAVEs). Current evidence
suggests that WAVEs are crucial for cell motility and meta-
stasis. This is a review on the possible role of WAVEs in
cancer and the clinical associations found in human cancer.
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1. Introduction
Cancer metastasis and cell migration. Migration of cancer
cells is critical for metastasis, from the first stage to the final
one where metastatic cancer cells settle in a secondary organ.
The ability to migrate and invade tissues allows cancer cells
to proliferate within tissues (growth), expand to adjacent
tissues (invasion), and travel to distant organs (metastasis) (1).
Metastases, rather than primary tumours, are responsible for
most cancer deaths (2). Tumour invasion is a complex process
involving several strategies, including mesenchymal and
amoeboid movements, by which cells move through tissues (3).
Cell migration through the extracellular matrix (ECM) begins
with the formation of cell protrusions that contain filamentous
actin (F-actin) and recognise the external environment; this is
a common feature of invasion. Thus, it may be possible to
control the invasive and metastatic phenotypes of cancer cells
by manipulating the proteins contributing to such protrusions.
It was demonstrated that invasive cancer cells acquire a
migratory phenotype associated with an increased expression
of several genes involved in cell motility (4). Migration through
tissues and endothelial barriers are a complex series of events
involving a highly regulated cycle of cell protrusion, retraction,
adhesion, detachment, and major dynamic rearrangements of
the actin cytoskeleton. Actin, which is the most abundant
protein with a concentration higher than 100 μM in most
eukaryotic cells, is found in the highest density at the cell peri-
phery. The shape of a cell is determined by actin filaments
which are necessary for whole-cell locomotion. Cancer cells
move within tissues during invasion and metastasis by their
own motility. Control of cancer cell migration is an important
problem in tumour treatment. Also, actin filaments in response
to a positive stimulus, form many cell surface projections.
Various signalling molecules that regulate multiple processes
are involved in cell migration (5). The actin cytoskeleton and
its regulatory proteins are crucial for cell migration in most
cells. The actin cytoskeleton is dynamically remodeled during
cell migration and this reorganisation produces the force
necessary for cell migration (6). Actin-related protein (Arp) 2/3
complex-dependent actin polymerisation and its regulation are
of particular interest. Reorganisation of actin filaments is
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regulated by a highly integrated signalling cascade governed
by ‘molecular switches’ belonging to the Rho family. Among
the members of the Rho family, RhoA, Cdc42 and Rac play a
key role by which the signalling inputs converge thereby initi-
ating output pathways leading to site-directed actin polymer-
isation (7). This family is associated with the metastatic pheno-
type through regulation of cellular motility and invasiveness
(8). Rac and Cdc42 stimulate formation of protrusions at the
leading edges of cells while RhoA induces retraction at the tail
ends of cells. Also important, are downstream molecules which
are directly involved in actin reorganisation and form links
between GTPases and the actin cytoskeleton. They belong to
a group known as the Wiskott-Aldrich Syndrome protein
(WASP) family proteins (9). 
WASP family proteins are the final downstream effector
linking the GTPases to the Arp complex, which are then
activated to carry out actin polymerisation. The term WASP is
derived from the clinical condition called the ‘Wiskott-Aldrich
Syndrome’ which is characterised by manifestations in the
immune system due to malfunctions of the actin cytoskeleton.
The syndrome is linked to the mutation of the Wiskott-Aldrich
Syndrome protein gene.
Wiskott-Aldrich Syndrome (WAS) and WAS protein (WASP)
family proteins. Wiskott-Aldrich Syndrome (WAS) is an X-
linked primary immunodeficiency originally described as a
clinical triad of immunodeficiency, thrombocytopenia, and
eczema (10). The presentation of this syndrome varies among
patients. Some express the full triad of clinical manifestations
while others have a milder phenotype and survive to adulthood.
Phenotypic expression varies over time in a given patient (11).
Patients with autoimmune and inflammatory manifestations
are usually in a high-risk group with poor outcome.
The WASP gene. The WASP gene was mapped to the region
Xp11.22-Xp11.3 after extensive studies of DNA from large
WAS families with multiple affected members (12). By means
of positional cloning and based on these mapping data,
Derry et al (13) isolated the WASP gene and observed
mutations in lymphoblastoid cell lines from patients with
WAS-XLT. The WASP gene encodes a 502-amino-acid
intracellular protein (WASP) expressed exclusively in
haematopoietic cells. Patients with WAS and WASP-deficient
mice have defective migratory behaviour of macrophages and
dendritic cells. WASP-deficient dendritic cells exhibit similar
abnormalities of cytoarchitecture, chemotaxis, and quality of
migration (14). Defects of migration, anchorage, and local-
isation were also present in other cell lineages, including T and
B lymphocytes, neutrophils, and haematopoietic stem cells
(HSCs) (15).
Additional members of the WASP family. After the identi-
fication of WAS and WASP (13), an isoform was later isolated
from the brain and called neural WASP (N-WASP). Although
its discovery came later it is widely expressed. A protein related
to WASP was identified in a genetic screen in Dictyostelium
and named Scar, as disruption of the Scar gene suppresses
abnormalities caused by loss of one of the cARs (cAMP
receptors), namely cAR-2 (16). In the same year, a mammalian
homologue of Scar was isolated independently by two groups
(17,18). One group retained the name Scar and the other
named the protein WAVE (WASP family verprolin homo-
logous protein); the names are used interchangeably (WAVEs/
Scar Proteins).
To date, five mammalian WASP family proteins have
been identified: WASP, N-WASP, and WAVE1, 2, and 3.
These proteins share two main regions of homology: a central
segment rich in proline residues and a carboxy-terminal module
comprising three characteristic domains called the VCA
domain. While the V domain is a monomeric actin binding
site, the CA domain binds the Arp2/3 complex. The Arp2/3
complex is activated when bound by the VCA domain and this
complex then catalyzes actin polymerisation. N-WASP was
first purified from bovine brain and is expressed ubiquitously,
particularly enriched in the brain (19). N-WASP shares 50%
homology with WASP. N-WASP induces filopodium
formation downstream of Cdc42 activation (20). This then
induces a conformational change that releases auto-inhibition
(21). Activated N-WASP then binds to the Arp2/3 complex
and induces rapid actin polymerisation.
2. Structural homology and divergence of the WASP
family proteins
All members of the WASP family share a similar modular
organisation with a conserved C-terminal ‘output’ domain and
a much larger and divergent N-terminal region involved in
targeting and regulating the activity of the output domain. This
domain initiates the growth of new actin filaments by bringing
together actin monomers and the actin-nucleating Arp2/3
complex. This is achieved through a VCA module consisting
of a verprolin homology domain [V domain, also called WASP
homology (WH) 2 domain] that binds to an actin monomer, a
C-terminal acidic (A) region that associates with the Arp2/3
complex and intermediates conserved sequence (C), named
the Cofilin domain. The C region acts in concert with the V
and A regions, driving the conformational changes of Arp2/3
that are necessary to stimulate nucleation. Comparative ana-
lysis of the catalytic properties of the VCA module of WASP,
N-WASP and WAVE revealed that the isolated domains
displayed the unique kinetics of actin assembly. The VCA
domain of N-WASP has a distinctly higher rate of nucleation
than the VCA of both WASP and WAVE domains which are
distinctly shorter and have less charge. 
The amino-terminal half of the molecule defines two
functional groups on the basis of the presence of either WASP
homology 1/Ena VASP homology 1 (WH1/EVH1) domain
(found in WASP and N-WASP) or WAVE homology domain
suppressor of cAMP receptor (SCAR) homology domain
(WHD/SHD), specific to WAVE isoforms. This is discussed in
detail in the following sections.
Functional role of the N-terminal domain of the WASP family
proteins. The overall conservation among the WASP and
WAVE family members within the catalytic VCA domain
contrasts the divergence of their N-terminal portion, which
includes >85% of the entire amino acid sequence. WASP and
N-WASP display a common modular organisation, including
the WH1 domain [also called enabled/vasodilator-stimulated
phosphoprotein (Ena/VASP) homology 1], a basic region (B),
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a GTPase-binding domain (GBD) [also called CRIB (Cdc42
and Rac interactive binding domain)] and a proline-rich region.
The WH1 domain includes the first 150 amino acids (22).
Twenty-eight of the 35 identified missense mutations that
cause Wiskott-Aldrich Syndrome lie within this domain and
therein lies its functional importance (23). This provides a
mechanism for explaining some of the manifestations of
Wiskott-Aldrich Syndrome because amino acid exchanges in
the WH1 domain resulting from mutations in the WASP gene
lead to a disruption of interaction with WIP family members,
resulting in protein malfunction. 
The B, GBD, and proline-rich regions are implicated in
regulating WASP and N-WASP functions, either by mediating
auto-inhibitory interactions that block the VCA domain output
activity, as in the case of the B and GBD regions, or by revers-
ing this inhibition (24). The GBD region is also known as the
CRIB region (25). The unlocking of the auto-inhibitory
interactions occurs by binding to upstream activators. While
activated Cdc42 containing GTP interacts with GBD,
PtdIns(4,5)P2 interacts with the B domain. A plethora of Src-
homology (SH)3-containing proteins (26,27) associate with
the proline-rich residues. Moreover, the B and proline-rich
regions are implicated in F-actin (28) and profilin (29,30)
binding, respectively. 
The N-terminal region of WAVE proteins is much less
characterised. In contrast to WASP and N-WASP, WAVE
proteins do not contain CRIB or the WH1 domains. They lack
a surface for direct linking to Rho GTPases. Consistent with
this, WAVE proteins instead possess an N-terminal conserved
region, known as the WAVE homology domain (WHD)
(18,24). This region displays a significant sequence similarity
to WH1 of WASP and N-WASP, implying that it might fold
in an analogous fashion. However, the functional roles of
WASP/N-WASP and WAVE members are distinct. The WHD
domain does not bind to WIP but mediates direct binding to
Abl-interacting protein 1 (Abi1) (31), a scaffolding molecule
originally identified as a mediator for the non-receptor tyrosine
kinase Abl (32), involved in Ras to Rac signalling (33). This
interaction is crucial for the assembly of a WAVE-based
macromolecular complex, which mediates a direct association
with activated Rac and positively regulates in vitro WAVE2-
Arp2/3-dependent actin polymerisation (34,35). Also similar
to WASP and N-WASP, WAVE proteins contain a B and
proline-rich region. The latter mediates the association with
insulin receptor substrate (IRS) p53 and is implicated in phys-
ically linking WAVE2 and Rac (36). 
3. Signal integration by WASP family proteins:
Mechanism for activation of the Arp2/3 complex
The WASP/N-WASP model of signal integration. As previously
reported (21,31), WASP and N-WASP exist as auto-inhibited
monomers in vitro and, possibly in vivo, as suggested by the
observation that ectopic expression of full-length N-WASP has
no effect on actin dynamics (20). To transform to an active
state, N-WASP requires a positive external stimulus and is
based on several protein-protein and protein-lipid interactions.
In the N-WASP closed conformation, the N-terminal B
region and the GBD are packed over hydrophobic residues of
the C domain in the VCA module, essential for activation of
Arp2/3 (31,32,37). Two possible mechanisms are proposed for
how the WASP molecule is kept inactive in vivo. One theory
proposes that both the B and CRIB regions act as a cooperative
unit that directly binds to the VCA-Arp2/3 complex imposing
structural constraints that prevent catalytic activation of Arp2/3
(‘direct inhibition model’) (31,32). The second theory proposes
that CRIB is sufficient in itself to sequester the VCA domain in
a dormant state (‘sequestration model’) (35). 
Cooperative binding of PtdIns(4,5)P2 and Cdc42 to the B
and CRIB regions, respectively, is required for operational
molecules. This causes a conformational change resulting in
the release of the C terminus, enabling its interaction with, and
activation of Arp2/3. This cooperative activation mechanism
demonstrates how combinations of simple binding domains are
used to integrate and amplify coincident signals. Reinforcing
this view, WASP and N-WASP regulation are exerted through
two additional signal-dependent mechanisms: (i) by binding
to several SH3-domain-containing signalling proteins and (ii)
by phosphorylation (38,39). For example, the SH2 and 3
adaptor Grb2, a weak activator by itself, cooperates with
Cdc42 to elicit full WASP and N-WASP activity, similar to
the actions of Nck and PtdIns(4,5)P2 (26). By contrast,
WASP-interacting SH3 protein (WISH) can elicit maximal
activation of N-WASP in a Cdc42-independent manner. The
biochemical effects of the association of other SH3-containing
signalling molecules, such as Src, Fyn, p85 and phospholipase
CÁ, with WASP and N-WASP are yet to be described. Several
endocytic proteins [endophilin A, intersectin and syndapin
(or pacsin1)] might modulate N-WASP activity, suggesting its
involvement in trafficking or internalisation processes. These
studies support a role for WASP and N-WASP as convergent
‘nodes’ of different signalling pathways for the execution of
actin-dependent processes. A final level of integration and
regulation is exerted by phosphorylation. WASP and N-WASP
are phosphorylated on both serine and tyrosine residues
(34,39). Constitutive phosphorylation by caseine kinase 2 of a
serine located within the VCA domain increases the nucleation-
promoting activity of WASP. Src family kinases (also focal
adhesion kinase) mediate signal-dependent phosphorylation
of both WASP and N-WASP on Y291 and Y253, respectively.
This post-translational modification synergises with
PtdIns(4,5)P2, leading to maximal WASP activation. Also,
the observation that tyrosine phosphorylation, in addition to the
subsequent dephosphorylation, occurs only in the presence of
activated Cdc42 suggests a mechanism for regulation of
initiation, duration and amplitude of N-WASP activation (40). 
The WAVE model of signal integration: Similarities and
differences to the WASP/N-WASP model. The WAVE proteins
lack the CRIB domain (as in WASP and N-WASP), hence no
direct link between them and Rho GTPases is possible for actin
reorganisation. Nevertheless, WAVE proteins function down-
stream of Rac in mediating membrane protrusion, as indicated
by the fact that WAVE1 dominant negative mutants abolish
Rac-dependent ruffling and neurite extension (41). As
mentioned before, another distinct difference between the
WAVE family members and N-WASP/WASP is that WAVEs
are inherently active under normal circumstances, suggesting
that a specific and separate mode of regulation exists (26).
Also, WAVE assembles into multimolecular complexes to
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function in vivo (43). Once activated, these complexes serve as
a link from the signal to the Rac molecules, regulating the
nucleation activity of the WAVEs. This ensures that it is
spatially restricted to the leading edge of the cell, where pro-
trusion is initiated. Both positive and negative modes of regu-
lation of the AVE complexes have been reported. As mentioned
earlier, IRSp53 acts as a link binding WAVE2 to activated Rac.
This is unique to WAVE2 and is not observed in WAVE1
and 3.
The ‘trans-inhibitory theory’ proposes an alternative
mechanism for control of WAVE proteins (44). This suggests
that WAVE1 is kept dormant by its association to four other
proteins Nap1 (an Nck-associated protein), PIR121 or Sra-1
(identified as Rac effectors) (45), and HSPC300 (a small 9-kDa
protein). In in vitro studies, this complex could not stimulate
actin polymerisation. However, addition of activated Rac
removed this inhibition by inducing the disassembly of the
inhibitory Nap1-PIR121 sub-complex from the WAVE1-
HSPC300 unit. Though this theory provides an attractive
explanation, it does not account for the mechanisms through
which the activity of the complex is restricted to specific sites
within cells destined for the formation of membrane extensions.
Another detailed study on the individual components of the
Abi1-Nap1-PIR121 concluded that Abi1 is an essential com-
ponent which directly interacts with the WHD domain of
WAVE2. Both WAVE1/2-Abi1-Nap1-PIR121 reconstituted
in vitro were as active as the WAVE1/2-Abi1 subcomplexes,
respectively, at stimulating actin nucleation. Also, the addition
of activated Rac either in vitro or in vivo did not disrupt the
complex (31,33). Studies of Drosophila and mammalian cell
lines confirmed that WAVE proteins form stable complexes
that are not disrupted following Rac activation or during cell
migration. Studies in which each of the molecules i.e.,
WAVE, Nap1, PIR121/Sra1 and Abi1 were knocked down in
Drosophila, S2 Schneider cells (46,47) and mammalian cells
showed that this manipulation resulted in complete loss of Rac-
induced actin remodelling and lamellipodia formation. Another
function of this complex inferred from this observation is that
individual ablation of Abi1 or any other component of the
complex lead to the degradation of WAVE molecules. This
indicates that proper assembly of the complex is required for
WAVE stabilisation. 
4. Functions of WAVE family proteins in cancer cell
migration
Two major physiological roles are described for WASP family
proteins with respect to migration and invasion of cancer cells
in 3-D matrices. These are the regulations of mesenchymal cell
migration and the degradation of extracellular matrix (ECM).
The WASP family proteins regulate these processes through
the formation of various actin-based protrusive membrane
structures down-stream of Rac and Cdc42 activation.
WAVE 1 and formation of dorsal ruffles, podosomes and
invadopodia. Characteristic protrusive membrane structures
are involved in ECM degradation in some invasive cells.
These structures have been variably named as dorsal ruffles,
podosomes, and invadopodia (48). Formation of these unique
structures is also regulated by WASP family proteins.
Dorsal ruffles. On stimulation by growth factors, a dramatic
change in dorsal membrane structures was observed in fibro-
blasts as well as epithelial cells. These protrusive membrane
structures are known as dorsal ruffles. However, not much is
known about their physiological functions. A study which
analysed the functions of WAVE1-deficient cells showed that
dorsal ruffles are involved in ECM degradation. Stimulation of
mouse embryonic fibroblasts (MEF) by PDGF results in
formation and induction of dorsal ruffles. Also, accumulation
of the ECM-degrading enzyme, MMP-2, occurs at the dorsal
ruffles. However, this formation of dorsal ruffles and lamelli-
podial protrusions are dependent on Rac. WAVE2 has no
similar functions in dorsal ruffle formation as does WAVE1.
A WAVE1 deficiency decreases dorsal ruffle formation and
subsequent MMP secretion. While normal chemotactic migra-
tion toward PDGF is seen in WAVE1-deficient MEF, chemo-
tactic invasion into the ECM toward PDGF is decreased. Dorsal
ruffles are formed only when cells are cultured on 2-D sub-
strates. It is unknown what form they take in 3-D matrices.
The relationship between dorsal ruffle structure and chemo-
tactic invasion remains to be determined. However, it is clear
that WAVE1-mediated protrusive membrane structures are
crucial for migration within ECM.
Podosomes and invadopodia. Invadopodium formation occurs
in highly invasive cancer cells, thus is implicated in tumour
cell metastasis. Podosomes have a remarkable similarity to
invadopodia in molecular composition. 
Podosomes are dynamic actin-rich adhesion structures that
form cell-substrate adhesion sites. These differ from focal
adhesions usually observed in adhesive cells. Podosomes are
formed by monocyte-derived cells, such as macrophages, some
nonhaematopoietic cells and by transformed fibroblasts (49). In
oncogene transformed cells these are named invadopodia (50).
EGF stimulates invadopodium formation in carcinoma cells,
indicating that invadopodium formation is regulated by chemo-
tactic and invasive signals (51). Podosomes and invadopodia
are involved in ECM degradation. Alhough the distinction
between these structures is unclear, it is known that invado-
podia persist longer than podosomes and many believe that
these could be the precursors of invadopodia. However, podo-
somes are observed only in limited cell types like osteoclasts
and macrophages. WASP is involved in the formation of
these structures (52). Podosomes consist of filamentous actin-
rich cores and surround ring structures containing adhesive
proteins such as vinculin and talin. When Src-transformed cells
are cultured on fibronectin, an ECM protein, spot-like degra-
dation of this protein is observed which colocalise with podo-
somes. N-WASP is recruited to podosome structures and is
essential for podosome formation. Expression of a dominant-
negative form of N-WASP, which cannot induce Arp2/3
complex-dependent actin polymerisation, proved inhibition of
podosome formation and therefore subsequent degradation of
ECM. Recent studies using RNAi methods for gene silencing
also demonstrated the role of N-WASP in invadopodium
formation in metastatic carcinoma cells (53).
WAVE2 and its role in mesenchymal migration. WAVE2 is
concentrated at the tips of membrane protrusions formed in
the direction of cell locomotion when a cell migrates (54,55).
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Recruitment to the leading edge is mediated by binding basic
residues in WAVE2 to PIP3i. Downstream of Rac, WAVE2
induces Arp2/3-mediated actin polymerisation, causing lamel-
lipodium formation (37), which is crucial for mesenchymal
cell migration. Lamellipodia are thin, flattened structures that
consist of branched actin networks (50). WAVE proteins
activate the Arp2/3 complex, which then bind to the pre-
existing actin filaments and induce new side-branched actin
polymerisation. Of all the WAVE proteins, it is predominantly
in the fibroblasts where WAVE2 is localised to the tips of
lamellipodial protrusions. Studies show that in WAVE2-
deficient fibroblasts, lamellipodium formation is severely
inhibited. Also in WAVE2-deficient cells, defective lamelli-
podium formation leads to decreased cell migration and inva-
sion toward chemoattractants. Thus, WAVE2 is important for
directional movement in fibroblasts (54). WAVE2 also plays a
role in the migration of B16F10 melanoma cells, which undergo
mesenchymal migration in 3-D matrices (56). Yamazaki et al
showed that repression of WAVE2 expression by RNAi
methods, reduces cancer cell migration and metastasis into the
lungs by B16F10 melanoma cells via regulation of membrane
protrusions (57). Thus, WAVE2 is essential for mesenchymal
migration, and inhibition of the WAVE2 function can inhibit
migration and invasion of cancer cells.
Role of WAVE3 in lamellipodium formation. The function of
WAVE3 discovered last among the WASP family. Knock-
down of WAVE3 expression by RNAi techniques prevented
the PDGF-induced lamellipodium formation and cell mi-
gration, while increasing actin stress fibers linked to focal
adhesion, which are generally associated with static cells.
This study showed that knockdown of WAVE3 expression
also inhibited the expression levels of MMP-1, -3, and -9. The
WAVE3-mediated MMP production is independent of both
WAVE1 and 2, whose expression levels were not affected by
loss of WAVE3. Endogenous WAVE3 was concentrated in
the lamellipodia at the leading edge of migrating MDA-MB-
231 cells. Down-regulation of WAVE3 impaired motility and
invasiveness of these cells. Treatment of cells with LY294002,
an inhibitor of phosphatidylinositol 3-kinase (PI3K), also
abrogated the PDGF-induced lamellipodium formation and
cell migration, suggesting that PI3K may be required for
WAVE3 activity. These findings confirm that WAVE3
regulates actin cytoskeleton, cell motility, and invasion through
the p38 mitogen-activated protein kinase (p38 MAPK) path-
way and MMP production, which act as downstream effectors
of WAVE3 in cell motility and invasion (58). 
5. Genomic organisation and expression of the human
WAVE gene family
The 3 human WAVE genes are fully characterised (18,19,59).
WAVE1 is primarily expressed in the brain and lung, although
a detectable PCR product is also observed in the placenta,
liver, and pancreas. These results extend previously published
data generated from a less sensitive Northern blot analysis
where WAVE1 was expressed exclusively in the brain (18,60).
Human WAVE2 expression was detected only in the placenta
and lung. Similar to WAVE1, WAVE 2 is ubiquitously ex-
pressed in all human fetal tissues. WAVE3 is predominantly
expressed in the brain, although a noticeable expression is
also detected in other tissues such as lung, testis, kidney, and
skeletal muscle. 
6. Human WAVE protein sequence alignments
Human WAVE1 protein is 549 amino acids long, while the
human WAVE2 and 3 are 488 and 501 amino acids, respec-
tively. The overall similarity between all three proteins is
>50%, but the similarity in the functional domains, i.e., the
basic, the proline-rich, and the VCA domains, and the leucine
zipper motif are >80%, which demonstrates a likely functional
conservation of these proteins among mammals. Moreover,
these functional domains were conserved in lower organisms
such as Drosophila, C. elegans, and Dictyostelium discoideum
apart from mice (61). The high degree of evolutionary conser-
vation of these genes from yeast to mammals clearly indicates
that their function is critical in the actin polymerisation and
cytoskeleton organisation processes.
WAVE3 is currently the only gene associated with a
human disorder. Sossey-Alaoui et al have previously shown
that WAVE3 is inactivated in low-grade neuroblastoma
tumours (62). This indicates that neuroblastoma might be a
consequence of disruption of the actin polymerisation and
cytoskeleton organisation machineries. This hypothesis is
further supported by the findings that IGF-I, which is also
involved in actin polymerisation and cytoskeleton organisation,
promotes motility in neuroblastoma cells by increasing the
amount of dynamic morphological changes, as measured by
the formation of large lamellipodia (63). 
7. Gene conservation among the WAVE family members
The human WAVE1, 2, and 3 genes map to chromosome
regions 6q21, 1p36, and 13q12, respectively (18,62). While
the WAVE1 gene maps distal to the human GPR6, 3 and 12,
two other members of the extended GPR gene family, map
distal to WAVE2 and proximal to WAVE3. HMG17 and 1,
two members of the large, high-mobility gene family, are also
found in the same order i.e., proximal to WAVE2 and distal
to WAVE3 which suggests that WAVE genes may have a
common origin and ancestor via duplication.
8. Clinical associations of WASPs with human cancer
Despite the pivotal role of the WASP family in cell and cell
migration, its role in human and clinical cancer is only recently
coming to light.
Expression of WAVEs and N-WASP in human breast cancer
and association with clinical outcomes. Various reports showed
associations between the expression of the WAVE family
members with clinical human cancer. Sossey-Alaoui et al
(64) recently reported that in tumour specimens from breast
cancer patients of different stages and grades, immuno-
histochemistry with polyclonal antibodies to WAVE3 showed
approximately 3-fold higher levels of WAVE3 were present
in grade III tumours compared with grade I tumours. Little or
no WAVE3 protein was detected in either normal breast or
grade I tumours. Also, an inverse correlation was observed
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between the oestrogen receptor/progesterone receptor status
and WAVE3 levels (64). In a separate study using an ortho-
topic xenograft model (mammary fat pads of female SCID
mice), they implanted MDA-MB-231 cells as well as cells with
WAVE3 gene silencing. In the control group, palpable tumours
were detected 15 days after inoculation. In the shWAVE3
groups, the tumours were first palpable much later (22 days and
40 days in 2 clones). Also, the tumour growth rate in the
shWAVE3 cohorts was reduced by 40 and 80% for these
clones. Finally, they also showed that spontaneous metastases
to the lungs in WAVE3 knockdown clones were significantly
reduced (p<0.00001). They concluded that suppression of
WAVE3 attenuated the establishment of primary tumours of
MDA-MB-231 cells in SCID mice (51). 
A similar association was reported between WAVE
members and breast cancer. In this analysis, the expression of
WAVE molecules at the mRNA and protein levels in a cohort
of 122 human breast cancer and 32 normal breast tissues, over-
expression of WAVE2 was seen in node-positive cases as well
as moderately and poorly differentiated tumours. A general
trend of high expression of these proteins was observed in
breast tumour tissues when compared with normal tissues.
Finally, patients who died of breast cancer had high WAVE1,
2 and 3 levels and of these WAVE2 levels showed statistical
significance (p=0.02) (41). The same group also reported that
expression of N-WASP transcripts is reduced/lost in breast
tumours, a change linked to a poor clinical outcome. In
addition, the group demonstrated that forced expression of N-
WASP in human breast cancer cells, MDA-MB-231, resulted
in less invasive cells (62).
Expression of WAVEs in liver tumours. Expression of WAVE2
was investigated in clinical hepatocellular carcinoma (HCC)
(65). Samples from 112 HCC patients were immunohisto-
chemically stained for WAVE2. The findings correlated with
clinical prognosis. Among these 112 cases, significant increases
in WAVE2 expression levels were observed in 71 cases. More
significantly, the increased WAVE2 expression correlated with
the multinodularity, absence of capsular formation, higher
Edmondson-Steiner grade, venous invasion and a shortened
median survival time, all of which were statistically significant
(p<0.05). By multivariable Cox regression analysis, high
WAVE2 expression [risk ratio (RR), 1.68, p=0.038], high
serum ·-fetoprotein levels, multiple tumour nodules and vein
invasion were independent prognostic factors for survival.
This immunohistochemistry data were confirmed by results of
reverse transcription-PCR and Western analysis of 31 HCC
cases, in which the WAVE2 mRNA and protein in HCC tissues
were significantly elevated when compared with paracarcino-
matous liver tissue. The conclusion from this study was that
WAVE2 could be a candidate prognostic marker for HCC.
Expression of WAVE2 and Arp2/3 in colorectal cancer.
Another report studied a large cohort of colorectal cancer
patients. This study used tissues collected over a 13-year period
from 1987 (66). There were 29 cases for which tissue blocks
of metastatic deposits in the liver as well as the primary
tumour available. Seven of these were synchronous and the
rest were metachronous. The immunohistochemical staining
showed absence of distinct colocalisation of Arp2 and WAVE2
in normal epithelial cells, though the immunoreaction of
either Arp2 or WAVE2 was seen focally. Because these cells
are thought to function while migrating in tissues, cells that
co-express Arp2 and WAVE2 may have greater ability to
move freely than cells that do not. This could partially explain
why cells which co-expressed both Arp2 and WAVE2 could
migrate actively. This present study demonstrated that the
colocalisation of Arp2 and WAVE2 is an independent risk
factor for liver metastasis in colorectal cancer. This group
obtained paired mirror sections of 154 cancer specimen
matches for parameters such as the site of origin, the T stage,
age and gender of patients. Expression of both Arp2 and
WAVE2 was detected in the same cancer cells in nearly 36%
of cases, but no co-expression was detected in normal colonic
epithelial cells. Univariate analysis showed that the colocal-
isation was significantly predictive of liver metastasis (RR,
8.760). This risk ratio is higher than other currently known
risk factors viz., histological grade (RR, 2.46), lymphatic
invasion (RR, 9.95), and tumour budding (RR, 4.00). Among
these, colocalisation and lymphatic invasion were independent
risk factors by multivariate analysis. Further mRNA studies
showed that high levels of Arp2, expressed by cancer cells,
were significantly associated with liver metastasis. These
results indicate that colocalisation of Arp2 and WAVE2 is an
independent risk factor for liver metastasis of colorectal
carcinoma. To further discuss the role of these proteins in
metastasis, this significant study using a murine model is
mentioned below. 
WAVEs in melanoma. In their study on murine melanoma
cells, Kurisu et al demonstrated that malignant B16F10 mouse
melanoma cells expressed more WAVE1 and 2 proteins and
showed higher Rac activity than B16 parental cells, which
are neither invasive nor metastatic (67). Membrane ruffling,
cell motility, invasion into the ECM, and pulmonary metastasis
of B16F10 cells were suppressed by WAVE2 RNAi tech-
niques. In B16 and B16F10 melanoma cells, WAVE1 was co-
localised with F-actin in both peripheral and aberrant ruffles.
WAVE2 was also concentrated in membrane ruffles but
localised at the tips of both peripheral and aberrant ruffles.
Cytosolic signals for WAVE2 were weaker than those of
WAVE1, suggesting that WAVE2 functions at the very front
of actin-rich protrusions and may have a distinct role in
membrane extension. They further conducted in vivo studies
to examine the effect of WAVE1 knockdown of metastatic
deposits in the lungs of female C57BL/6 mice. When B16F10
cells were injected intravenously, they metastasised to the
lungs and formed black spherical colonies. Two weeks post-
injection, colonisation of the lung by B16F10 cells were
observed in vector transfectants and in cells with WAVE1
RNAi. In contrast, WAVE2 RNAi suppressed metastasis
of B16F10 cells to the lungs. This suggests that WAVE2
suppression may be an effective means to block invasion and
metastasis. There are several events in which WAVE2 may be
necessary. The colonisation cascade in lungs begins with
attachment of tumour cells to endothelial cells of microvessels.
Tumour cells then extend pseudopods into the subendothelial
matrix and penetrate endothelial linings to adhere to the base-
ment membrane. Finally, tumour cells extravasate with dis-
solution of the basement membrane (68). 
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WAVEs in prostate cancer. We recently investigated the role
of WAVEs and the pattern of expression in human prostate
cancer. Immunohistochemical studies of prostate tissue
specimens showed that prostate cancer tissue had a distinct
staining when compared to normal prostate epithelial tissues.
RT-PCR using the specific primer for WAVE1 showed good
expression in both PC-3 and DU-145 cell lines. WAVE1
knockdown cell clones were generated from both cells, which
showed a markedly reduced expression of WAVE-1 transcript,
as confirmed by RT-PCR and Western blot. It was found that
knockdown of WAVE1 was associated with significant
reduction in invasion (p<0.001, in both cell lines) but not
growth at 72 h (p>0.05, in both cell lines). Adhesion of cells to
the Matrigel was not affected by the knockdown of WAVE1
(p>0.05), thus indicating its pivotal role in the control of cell-
ular invasion (69). Our knockdown studies conducted on
WAVE3 for these cell lines were associated with decreased
invasiveness (p<0.05), but not cell growth (unpublished data). 
9. Conclusions and perspectives
It is clear from the current evidence that the WASP family,
particularly the WAVE proteins, are strongly linked to
migration of a variety of cells including cancer cells. These
proteins are also linked to the invasiveness and aggressiveness
of cancer cells. However, it is acknowledged that not all
pathways by which WAVEs accomplish actin nucleation are
known. Evidence is emerging that the abnormalities of the
WASP family proteins are linked to the clinical outcome of
patients. Together, it is reasonable to conclude that the
WASP family, and in particular the WAVEs, are key intrinsic
regulators of cancer cells and bear important implications in
the development of clinical cancers. Targeting these molecules
is crucial to our efforts to achieve cancer control. Actin
nucleation is a nodal point which is important for cell
metastasis. Hence, methods to block this step could prevent
metastasis. Further work needs to be carried out to elucidate
if WAVEs have a similar role in different types of cancers.
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